GENE ONLINE|News &
Opinion
Blog

Pfizer
Trials & Approvals Pfizer
Pfizer’s Potential GBS Vaccines Swipes Up the FDA’s Breakthrough Therapy Designation
2022-09-07
Trials & Approvals Pfizer
Pfizer’s Bivalent RSV Candidate Demonstrates 85% Efficacy in Phase 3 Trials
2022-08-26
M&A Pfizer
Pfizer Acquires Global Blood Therapeutics and its sickle cell disease expertise for $5.4 billion
2022-08-09
Trials & Approvals Pfizer
Myovant, Pfizer’s Endometriosis Pain Treatment Gets FDA Greenlight
2022-08-08
M&A Pfizer
Pfizer Reportedly in Talks of $5 Billion Global Blood Therapeutics Purchase
2022-08-08
Special Pfizer
Pfizer and Flynn Fined £70 Million in Epilepsy Drug Price Hike Scheme
2022-07-22
COVID-19 FDA
FDA Panel Suggests Redesigning Vaccines to Target Omicron Variants, Pfizer & Sanofi Share Booster Updates
2022-06-29
Trials & Approvals Pneumococcal Vaccine
FDA Blesses Merck’s Pneumococcal Vaccine for Pediatric Use
2022-06-23
Funding Pfizer
Valneva Receives Funding From Pfizer to Develop World’s Only Lyme Disease Vaccine
2022-06-21
Funding Series B Funding
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Special ASCO
ASCO 2022: AstraZeneca, Pfizer, Novartis Share Key Data on Breast Cancer Therapeutics
2022-06-07
COVID-19 Antiviral Treatment
Pfizer to Address COVID-19 Reinfection After Paxlovid Treatment
2022-05-19
M&A Pfizer
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
COVID-19 mRNA Vaccine
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
M&A Pfizer
ReViral Acquisition by Pfizer To Enhance Its Respiratory Syncytial Virus Therapeutic Portfolio
2022-04-10
1 2 3 4 5 … 9
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top